These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 33469596)

  • 1. Cerebrospinal fluid in COVID-19 neurological complications: no cytokine storm or neuroinflammation.
    Garcia MA; Barreras PV; Lewis A; Pinilla G; Sokoll LJ; Kickler T; Mostafa H; Caturegli M; Moghekar A; Fitzgerald KC; Pardo CA
    medRxiv; 2021 Jan; ():. PubMed ID: 33469596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebrospinal fluid in COVID-19 neurological complications: Neuroaxonal damage, anti-SARS-Cov2 antibodies but no evidence of cytokine storm.
    Garcia MA; Barreras PV; Lewis A; Pinilla G; Sokoll LJ; Kickler T; Mostafa H; Caturegli M; Moghekar A; Fitzgerald KC; ; Pardo CA
    J Neurol Sci; 2021 Aug; 427():117517. PubMed ID: 34090021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CSF Biomarkers in COVID-19 Associated Encephalopathy and Encephalitis Predict Long-Term Outcome.
    Guasp M; Muñoz-Sánchez G; Martínez-Hernández E; Santana D; Carbayo Á; Naranjo L; Bolós U; Framil M; Saiz A; Balasa M; Ruiz-García R; Sánchez-Valle R;
    Front Immunol; 2022; 13():866153. PubMed ID: 35479062
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma biomarker profiling of PIMS-TS, COVID-19 and SARS-CoV2 seropositive children - a cross-sectional observational study from southern India.
    Venkataraman A; Kumar NP; Hanna LE; Putlibai S; Karthick M; Rajamanikam A; Sadasivam K; Sundaram B; Babu S
    EBioMedicine; 2021 Apr; 66():103317. PubMed ID: 33813138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation.
    Kempuraj D; Selvakumar GP; Ahmed ME; Raikwar SP; Thangavel R; Khan A; Zaheer SA; Iyer SS; Burton C; James D; Zaheer A
    Neuroscientist; 2020; 26(5-6):402-414. PubMed ID: 32684080
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid cytokines in COVID-19: a review and meta-analysis.
    Devlin L; Gombolay GY
    J Neurol; 2023 Nov; 270(11):5155-5161. PubMed ID: 37581633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The brain reacting to COVID-19: analysis of the cerebrospinal fluid proteome, RNA and inflammation.
    Reinhold D; Farztdinov V; Yan Y; Meisel C; Sadlowski H; Kühn J; Perschel FH; Endres M; Düzel E; Vielhaber S; Guttek K; Goihl A; Venø M; Teegen B; Stöcker W; Stubbemann P; Kurth F; Sander LE; Ralser M; Otto C; Streit S; Jarius S; Ruprecht K; Radbruch H; Kjems J; Mülleder M; Heppner F; Körtvelyessy P
    J Neuroinflammation; 2023 Feb; 20(1):30. PubMed ID: 36759861
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrathecal inflammatory responses in the absence of SARS-CoV-2 nucleic acid in the CSF of COVID-19 hospitalized patients.
    Normandin E; Holroyd KB; Collens SI; Shaw BM; Siddle KJ; Adams G; Rudy M; Solomon IH; Anahtar MN; Lemieux JE; Trombetta BA; Kivisakk P; Arnold SE; Rapalino O; Piantadosi AL; Sen P; Rosenberg ES; Branda J; Sabeti PC; Mukerji SS
    J Neurol Sci; 2021 Nov; 430():120023. PubMed ID: 34678659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cerebrospinal fluid light and heavy neurofilament level increased in anti-N-methyl-d-aspartate receptor encephalitis.
    Li J; Gu Y; An H; Zhou Z; Zheng D; Wang Z; Wen Z; Shen HY; Wang Q; Wang H
    Brain Behav; 2019 Aug; 9(8):e01354. PubMed ID: 31313506
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebrospinal fluid and serum cytokine profiling to detect immune control of infectious and inflammatory neurological and psychiatric diseases.
    Maxeiner HG; Marion Schneider E; Kurfiss ST; Brettschneider J; Tumani H; Bechter K
    Cytokine; 2014 Sep; 69(1):62-7. PubMed ID: 25022963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in neuroinflammatory biomarkers correlate with disease severity and neuroimaging alterations in patients with COVID-19 neurological complications.
    Barros-Aragão FGQ; Pinto TP; Carregari VC; Rezende NBS; Pinheiro TL; Reis-de-Oliveira G; Cabral-Castro MJ; Queiroz DC; Fonseca PLC; Gonçalves AL; de Freitas GR; Sudo FK; Mattos P; Bozza FA; Rodrigues EC; Aguiar RS; Rodrigues RS; Brandão CO; Souza AS; Martins-de-Souza D; De Felice FG; Tovar-Moll F
    Brain Behav Immun Health; 2024 Aug; 39():100805. PubMed ID: 39022627
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytokine Storm and Neuropathological Alterations in Patients with Neurological Manifestations of COVID-19.
    Tsagkaris C; Bilal M; Aktar I; Aboufandi Y; Tas A; Aborode AT; Suvvari TK; Ahmad S; Shkodina A; Phadke R; Emhamed MS; Baig AA; Alexiou A; Ashraf GM; Kamal MA
    Curr Alzheimer Res; 2022; 19(9):641-657. PubMed ID: 36089786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can Neuron Specific Enolase Be a Diagnostic Biomarker for Neuronal Injury in COVID-19?
    Ganti L; Serrano E; Toklu HZ
    Cureus; 2020 Oct; 12(10):e11033. PubMed ID: 33214960
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-SARS-CoV-2 antibodies in the CSF, blood-brain barrier dysfunction, and neurological outcome: Studies in 8 stuporous and comatose patients.
    Alexopoulos H; Magira E; Bitzogli K; Kafasi N; Vlachoyiannopoulos P; Tzioufas A; Kotanidou A; Dalakas MC
    Neurol Neuroimmunol Neuroinflamm; 2020 Nov; 7(6):. PubMed ID: 32978291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 meningitis without pulmonary involvement with positive cerebrospinal fluid PCR.
    Khodamoradi Z; Hosseini SA; Gholampoor Saadi MH; Mehrabi Z; Sasani MR; Yaghoubi S
    Eur J Neurol; 2020 Dec; 27(12):2668-2669. PubMed ID: 32926584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid biomarkers in SARS-CoV-2 patients with acute neurological syndromes.
    Chaumont H; Kaczorowski F; San-Galli A; Michel PP; Tressières B; Roze E; Quadrio I; Lannuzel A
    Rev Neurol (Paris); 2023 Mar; 179(3):208-217. PubMed ID: 36610823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Coronavirus-Associated Coagulopathy: Lessons From SARS-CoV1 and MERS-CoV for the Current SARS-CoV2 Pandemic.
    Singh S; Zuwasti U; Haas C
    Cureus; 2020 Nov; 12(11):e11310. PubMed ID: 33282586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Utility of chemokines CCL2, CXCL8, 10 and 13 and interleukin 6 in the pediatric cohort for the recognition of neuroinflammation and in the context of traditional cerebrospinal fluid neuroinflammatory biomarkers.
    Liba Z; Nohejlova H; Capek V; Krsek P; Sediva A; Kayserova J
    PLoS One; 2019; 14(7):e0219987. PubMed ID: 31356620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased levels of interleukins 2 and 17 in the cerebrospinal fluid of patients with idiopathic intracranial hypertension.
    Edwards LJ; Sharrack B; Ismail A; Tench CR; Gran B; Dhungana S; Brettschneider J; Tumani H; Constantinescu CS
    Am J Clin Exp Immunol; 2013; 2(3):234-44. PubMed ID: 24179731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurological symptoms in COVID-19: a cross-sectional monocentric study of hospitalized patients.
    Ermis U; Rust MI; Bungenberg J; Costa A; Dreher M; Balfanz P; Marx G; Wiesmann M; Reetz K; Tauber SC; Schulz JB
    Neurol Res Pract; 2021 Mar; 3(1):17. PubMed ID: 33712089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.